SEC Company Response from NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Feb 6, 2012
NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: Feb. 6, 2012 · CIK: 0001072379 · Accession: 0001144204-12-006034
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-178958
Letter
VIA EDGAR ONLY United States Securities and Exchange Commission Attention: Jeffrey Riedler, Registration Statement on Form S-1 Filed January 10, 2012 File No. 333-178958
Re: Northwest Biotherapeutics, Inc.
Dear Mr. Riedler:
Please be advised that the undersigned is the duly elected Chief Executive Officer of Northwest Biotherapeutics, Inc. (the "Registrant"). Having been advised that the Commission has no further comments to the Registrant's Form S-1 Registration Statement, the Registrant hereby requests acceleration of the effective date of the Registration Statement to Wednesday, February 8, 2012 at 9:00 a.m., or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should you have any questions in regard to this correspondence or any other matter relating to this Registrant’s filing, please do not hesitate to contact me.
Very truly yours,
/s/ Linda Powers
Show Raw Text
CORRESP
1
filename1.htm
February 6, 2012
VIA EDGAR ONLY
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Jeffrey Riedler,
Assistant Director
Re: Northwest Biotherapeutics, Inc.
Registration Statement on Form S-1
Filed January 10, 2012
File No. 333-178958
Dear Mr. Riedler:
Please be advised that
the undersigned is the duly elected Chief Executive Officer of Northwest Biotherapeutics, Inc. (the "Registrant"). Having
been advised that the Commission has no further comments to the Registrant's Form S-1 Registration Statement, the Registrant hereby
requests acceleration of the effective date of the Registration Statement to Wednesday, February 8, 2012 at 9:00 a.m., or as soon
thereafter as practicable.
The Registrant hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority,
declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated
by the Commission or any person under the federal securities laws of the United States.
Should you have any questions in regard to this correspondence or
any other matter relating to this Registrant’s filing, please do not hesitate to contact me.
Very truly yours,
/s/ Linda Powers
Linda Powers
Chief Executive Officer